Many health care experts point to the creation of Medicare as the time that the American health care system's costs began to explode at an unsustainable rate. Simply, they believe that a huge infusion of government money drove both the supply and the demand for services setting the stage for today's cost problems.That has made many wonder what impact the new Medicare Part D drug benefit, which
Latest Post
Showing posts with label Drug Reimportation. Show all posts
Showing posts with label Drug Reimportation. Show all posts
Drug Patents and "Pay-For-Delay"--Drug Industry Payoffs That Need To End
I call your attention to a recent op-ed by a member of the Federal Trade Commission, Jon Leibowitz, in the Washington Post.Commissioner Leibowitz writes about the growing practice of "colluding with competitors to keep lower-cost generic alternatives to prescription drugs off the market."The Hatch-Waxman Act made it easier for generic drugs to enter the market once a name brand drug's patent has